John Scholler

13.8k total citations · 7 hit papers
68 papers, 7.0k citations indexed

About

John Scholler is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, John Scholler has authored 68 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 32 papers in Molecular Biology and 21 papers in Immunology. Recurrent topics in John Scholler's work include CAR-T cell therapy research (49 papers), Virus-based gene therapy research (14 papers) and Immune Cell Function and Interaction (13 papers). John Scholler is often cited by papers focused on CAR-T cell therapy research (49 papers), Virus-based gene therapy research (14 papers) and Immune Cell Function and Interaction (13 papers). John Scholler collaborates with scholars based in United States, Finland and Slovakia. John Scholler's co-authors include Carl H. June, Brian Keith, Sònia Guedan, Avery D. Posey, Steven Μ. Albelda, Shannon E. McGettigan, Michael C. Milone, Yangbing Zhao, Omkar U. Kawalekar and Prachi Patel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

John Scholler

63 papers receiving 6.9k citations

Hit Papers

Distinct Signaling of Coreceptors Regulates Specific Meta... 2012 2026 2016 2021 2016 2013 2012 2018 2015 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
    2016 887 citations Omkar U. Kawalekar, Roddy S. O’Connor et al. profile →
  2. Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity
    2013 515 citations Liang‐Chuan S. Wang, Albert Lo et al. Cancer Immunology Research profile →
  3. Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells
    2012 502 citations John Scholler, Michael Kalos et al. profile →
  4. Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation
    2018 430 citations Sònia Guedan, Avery D. Posey et al. JCI Insight profile →
  5. Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells
    2015 407 citations Albert Lo, Liang‐Chuan S. Wang et al. Cancer Research profile →
  6. Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18
    2017 400 citations Regina M. Young, John Scholler et al. profile →
  7. Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors
    2023 129 citations Zebin Xiao, Leslie Todd et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Scholler United States 29 5.5k 2.6k 2.3k 1.7k 1.7k 68 7.0k
Rimas J. Orentas United States 34 6.6k 1.2× 2.9k 1.1× 2.2k 0.9× 2.0k 1.1× 1.9k 1.2× 120 8.2k
Martin Pulé United Kingdom 42 7.2k 1.3× 3.3k 1.3× 3.0k 1.3× 2.7k 1.6× 2.5k 1.5× 149 9.4k
Steven A. Feldman United States 36 9.6k 1.8× 4.7k 1.8× 3.1k 1.3× 3.0k 1.7× 2.3k 1.4× 87 11.4k
Hinrich Abken Germany 58 8.0k 1.5× 4.7k 1.8× 2.8k 1.2× 2.4k 1.4× 2.3k 1.4× 219 10.2k
Omkar U. Kawalekar United States 13 3.1k 0.6× 1.8k 0.7× 1.3k 0.6× 768 0.4× 1.1k 0.7× 20 4.5k
Stephen Gottschalk United States 64 9.4k 1.7× 4.7k 1.8× 3.0k 1.3× 3.1k 1.8× 2.1k 1.3× 256 12.2k
Carmine Carpenito United States 22 4.3k 0.8× 2.8k 1.1× 1.6k 0.7× 1.4k 0.8× 1.2k 0.7× 37 5.8k
Isabelle Rivière United States 46 9.2k 1.7× 4.3k 1.7× 4.2k 1.8× 3.7k 2.2× 2.6k 1.6× 157 12.2k
Richard A. Morgan United States 44 4.8k 0.9× 2.8k 1.1× 2.7k 1.2× 2.5k 1.4× 877 0.5× 112 7.4k
Winfried S. Wels Germany 51 5.9k 1.1× 5.0k 1.9× 2.7k 1.2× 1.6k 0.9× 1.1k 0.7× 176 8.9k

Countries citing papers authored by John Scholler

Since Specialization
Citations

This map shows the geographic impact of John Scholler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Scholler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Scholler more than expected).

Fields of papers citing papers by John Scholler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Scholler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Scholler. The network helps show where John Scholler may publish in the future.

Co-authorship network of co-authors of John Scholler

This figure shows the co-authorship network connecting the top 25 collaborators of John Scholler. A scholar is included among the top collaborators of John Scholler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Scholler. John Scholler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shukla, Deepa, Khatuna Gabunia, Shannon E. McGettigan, et al.. (2025). CAR Binders Affect CAR T-cell Tonic Signaling, Durability, and Sensitivity to Target. Cancer Immunology Research. 13(6). 867–880. 1 indexed citations
2.
Mai, David, et al.. (2024). ZFP36 disruption is insufficient to enhance the function of mesothelin-targeting human CAR-T cells. Scientific Reports. 14(1). 3113–3113. 1 indexed citations
3.
Tilsed, Caitlin M., Tyler E. Papp, Kenji Kimura, et al.. (2024). IL7 increases targeted lipid nanoparticle–mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation. Proceedings of the National Academy of Sciences. 121(13). e2319856121–e2319856121. 24 indexed citations
4.
Kuramitsu, Shunichiro, Tong Da, Sangya Agarwal, et al.. (2023). Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma. Blood Advances. 7(14). 3416–3430. 27 indexed citations
5.
Noguera-Ortega, Estela, Zebin Xiao, Leslie Todd, et al.. (2022). Monitoring Therapeutic Response to Anti-FAP CAR T Cells Using [18F]AlF-FAPI-74. Clinical Cancer Research. 28(24). 5330–5342. 34 indexed citations
6.
Bear, Adham S., Tatiana Blanchard, Michael Ford, et al.. (2021). Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting. Nature Communications. 12(1). 4365–4365. 73 indexed citations
7.
Thakur, Archana, et al.. (2021). Bispecific Antibody Armed Metabolically Enhanced Headless CAR T Cells. Frontiers in Immunology. 12. 690437–690437. 13 indexed citations
8.
Castellarin, Mauro, Caroline Sands, Tong Da, et al.. (2020). A rational mouse model to detect on-target, off-tumor CAR T cell toxicity. JCI Insight. 5(14). 72 indexed citations
9.
Thakur, Archana, John Scholler, Dana L. Schalk, Carl H. June, & Lawrence G. Lum. (2020). Enhanced cytotoxicity against solid tumors by bispecific antibody-armed CD19 CAR T cells: a proof-of-concept study. Journal of Cancer Research and Clinical Oncology. 146(8). 2007–2016. 14 indexed citations
10.
Ghassemi, Saba, Selene Nuñez-Cruz, Roddy S. O’Connor, et al.. (2018). Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells. Cancer Immunology Research. 6(9). 1100–1109. 212 indexed citations
11.
Frigault, Matthew J., Ji‐Hyun Lee, Maria C. Basil, et al.. (2015). Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells. Cancer Immunology Research. 3(4). 356–367. 233 indexed citations
12.
Lo, Albert, Liang‐Chuan S. Wang, John Scholler, et al.. (2015). Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells. Cancer Research. 75(14). 2800–2810. 407 indexed citations breakdown →
13.
Moon, Edmund K., Liang-Chuan Wang, Douglas V. Dolfi, et al.. (2014). Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors. Clinical Cancer Research. 20(16). 4262–4273. 344 indexed citations
14.
Gill, Saar, Sarah K. Tasian, Marco Ruella, et al.. (2014). Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor–modified T cells. Blood. 123(15). 2343–2354. 363 indexed citations
15.
Wang, Liang‐Chuan S., Albert Lo, John Scholler, et al.. (2013). Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity. Cancer Immunology Research. 2(2). 154–166. 515 indexed citations breakdown →
16.
Zhao, Yangbing, Edmund K. Moon, Carmine Carpenito, et al.. (2010). Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor. Cancer Research. 70(22). 9053–9061. 366 indexed citations
17.
Martin, Unja, John Scholler, Jesse L. Gurgel, et al.. (2009). Externalization of the Leaderless Cytokine IL-1F6 Occurs in Response to Lipopolysaccharide/ATP Activation of Transduced Bone Marrow Macrophages. The Journal of Immunology. 183(6). 4021–4030. 40 indexed citations
18.
Skeiky, Yasir A. W., Mary K. Kennedy, David Kaufman, et al.. (1998). LeIF: A Recombinant Leishmania Protein That Induces an IL-12-Mediated Th1 Cytokine Profile. The Journal of Immunology. 161(11). 6171–6179. 131 indexed citations
19.
Scholler, John & Steven B. Kanner. (1997). The Human p167 Gene Encodes a Unique Structural Protein That Contains Centrosomin A Homology and Associates with a Multicomponent Complex. DNA and Cell Biology. 16(4). 515–531. 16 indexed citations
20.
Aline, Robert F., John Scholler, & Kenneth Stuart. (1989). Transcripts from the co-transposed segment of variant surface glycoprotein genes are in Trypanosoma brucei polyribosomes. Molecular and Biochemical Parasitology. 32(2-3). 169–178. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rimas J. Orentas Breakdown of academic impact, for papers by Martin Pulé Breakdown of academic impact, for papers by Steven A. Feldman Breakdown of academic impact, for papers by Hinrich Abken Breakdown of academic impact, for papers by Omkar U. Kawalekar Breakdown of academic impact, for papers by Stephen Gottschalk Breakdown of academic impact, for papers by Carmine Carpenito Breakdown of academic impact, for papers by Isabelle Rivière Breakdown of academic impact, for papers by Richard A. Morgan Breakdown of academic impact, for papers by Winfried S. Wels
Rankless by CCL
2026